Bisphosphonates after denosumab withdrawal reduce the vertebral fractures incidence.

The Dmab withdrawal is associated with an increased risk of clinical but not morphometric VFx. Therapy with ALN or with a single ZOL treatment is partially effective in reducing the increased VFx risk after Dmab withdrawal.